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Abstract The concept that the amino-terminal segment plays a
role in conferring high basal activity to protein kinase CK2 K
subunit has been validated by generating two mutants (Y26F and
v2^6) which are defective both in catalytic activity and in
thermal stability. The additional finding that the activity of the
two mutants is fully restored upon association with the regulatory
L subunit, in conjunction with the observation that synthetic
peptides reproducing the N-terminal segment (1^30) and the
activation loop (175^201) of CK2K counteract the functional
effects of the C-terminal domain of the L subunit, is consistent
with a mechanism of activation of CK2 where the N-terminal
domain of K and the C-terminal domain of L play interchange-
able roles.
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1. Introduction
Protein kinase CK2 (also known as casein kinase II) is a
ubiquitous and pleiotropic Ser/Thr protein kinase which is
highly conserved in evolution indicating a vital cellular role
for this protein kinase [1,2]. CK2 phosphorylates seryl and
threonyl residues which are speci¢ed by clusters of acidic de-
terminants, the one at position n+3 de¢ning the minimum
consensus (S/T-x-x-E/D) [3,4].
More than 160 targets of CK2 are currently known, includ-
ing enzymes involved in DNA, RNA and protein synthesis,
transcription factors, signal transduction mediators and other
nuclear factors [2]. CK2 activity is elevated in proliferating
and transformed tissues, including leukemias and solid tumors
[5^11]. A critical role of CK2 in the pathogenesis of cancer
has been demonstrated by over-expressing its catalytic K sub-
unit in lymphocytes of transgenic mice [12]. Moreover, the
presence of CK2 K transgene collaborates with c-Myc and
Tal-1 expression [12,13] and with p53 de¢ciency [14] in devel-
oping lymphomas in mice, while ectopic expression of CK2 K
and, even more, KP, synergizes with Ha-Ras in inducing trans-
formation of cultured ¢broblasts [15].
These observations highlight the importance of deciphering
the mode of regulation of CK2, which is still quite enigmatic.
CK2 holoenzyme is composed of two catalytic (K and/or KP)
and two ‘regulatory’ L subunits, to give very stable heterote-
tramers which apparently do not dissociate unless under de-
naturing conditions. There is evidence, however, that the free
catalytic subunits could be present in the cell under special
circumstances [15,16], and monomeric forms of CK2 com-
posed of isolated catalytic subunits have been found in plants
[17] and molds [18]. Both the holoenzymes and the isolated
catalytic subunits are endowed with spontaneous basal activ-
ity tested with either casein or peptide substrates, and are not
susceptible to tight control by either any known second mes-
senger or phosphorylation. However, unlike the catalytic sub-
units displaying basal activity toward all substrates tested so
far, the holoenzyme is inactive toward some protein sub-
strates, notably calmodulin [2]. This led to the discovery of
a dual function of the L subunit exerting both a positive and a
negative control [19], whose balance may result either in stim-
ulation of activity (as observed with most peptide substrates)
or in inhibition, as typically observed with calmodulin [20].
Such opposite e¡ects of the L subunit can be physically dis-
sected by generating large peptides reproducing its N- (1^77)
or C-terminal domains (155^215) mimicking either the inhib-
itory or the stimulatory e¡ects of full length L, respectively
[21]. In particular the C-terminal domain peptides are respon-
sible for tight association to the catalytic subunits and invar-
iably stimulate catalytic activity irrespective of the nature of
the phosphoacceptor substrate, calmodulin included [21].
The recent elucidation of the crystal structure of Zea mays
CK2K [22] has revealed a number of features that could ac-
count for its constitutive activity, the most remarkable being a
tight contact between the N-terminal region and the ‘activa-
tion loop’ which is therefore displaced from the catalytic cleft
and maintained in an open conformation. By contrast, in
cyclin dependent protein kinases (CDKs), belonging to the
same phylogenetic subgroup of CK2 [23], the N-terminal seg-
ment is lacking and the activation loop is oriented toward the
opposite direction keeping the catalytic subunit in its fully
inactive form. Partial activation of CDK2 requires the binding
of cyclin which makes contacts, among others, with the acti-
vation loop, displacing it toward an open conformation [24]
similar to the one which in CK2K is ensured by the N-termi-
nal segment [22].
It is conceivable therefore that constitutive activity is con-
ferred to CK2K and CK2 holoenzyme by two di¡erent struc-
tural elements, the N-terminal segment of K and the C-termi-
nal domain of L, respectively, both operating through the
activation loop. To validate this hypothesis we have generated
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two mutants of CK2K altered in their N-terminal segment
(Y26F and v2^6), and we have synthesized large peptides
reproducing the N-terminal segment and the activation loop,
potentially able to antagonize functional interactions between
the K and the L subunits. By these independent approaches we
have obtained evidence that indeed the N-terminal segment of
the K subunit and the C-terminal region of the L subunit play
interchangeable roles in keeping CK2 in its active conforma-
tion.
2. Materials and methods
2.1. Materials
[Q-32P]ATP (3000 Ci/mmol) was obtained from Amersham. Re-
combinant calmodulin was kindly provided by Prof. E. Carafoli
(Zuºrich, Switzerland). All other chemicals were obtained from Sigma.
The two oligonucleotides used during the preparation of the Kv2^6
mutant were synthesized by TIB MOLBIOL S.r.l.
2.2. Synthetic peptides
Peptide substrate RRRAADSDDDDD was synthesized as previ-
ously described [25]. The CK2K derived peptides were synthesized
using an automated peptide synthesizer ABI 431-A (Applied Biosys-
tems) equipped with HBTU/HOBt chemistry on a 4-(hydroxymethyl)-
phenoxymethyl-copolystyrene-1% divinylbenzene resin (Perkin Elmer)
and N-K-Fmoc amino acid derivatives (Novabiochem) according to
our own protocols (for details see [21]).
The crude peptides were puri¢ed by HPLC on a preparative reverse
column Prep Nova-Pak HR C18, 6 Wm, 25U10 mm (Waters). The
analytical HPLC and MALDI-TOF mass spectrometry analysis of the
puri¢ed peptides showed a correct sequence and a purity of 95%.
2.3. Mutagenesis and expression of CK2 subunits
The KY26F mutant was generated by oligonucleotide directed mu-
tagenesis as described in detail previously [26]. The N-terminal deleted
mutant Kv2^6 was obtained using the ‘QuickChange site-directed’ kit
(Stratagene). The coding region of human K cDNA was inserted in
vector pT7-7. Two synthetic oligonucleotide primers GGAGATATA-
CATATGAGCAGGGCCAGAGTTTAC, each complementary to
opposite strands of the vector, were used to delete 15 bp after the
ATG starting codon. The obtained clones were sequenced and the
positive clones were used to transform BL21(DE3) competent bacte-
rial cells. Expression and puri¢cation of K wt, KY26F, Kv2^6 and L
subunit were performed as described by Grankowski et al. [27].
2.4. Phosphorylation assay
Phosphorylation of synthetic peptide RRRAADSDDDDD (100
WM) was performed with 10 min incubation at 30‡C in 30 Wl of a
medium containing 50 mM Tris-HCl (pH 7.5), 12 mM MgCl2, 100
mM NaCl and 50 WM [Q-32P]ATP (speci¢c activity 300 cpm/pmol).
The reaction started with the addition of the enzyme and 32P incor-
poration was evaluated with the phosphocellulose paper procedure
[28]. In the case of calmodulin phosphorylation and CK2 autophos-
phorylation experiments the reaction was blocked by the addition of
Laemmli solution followed by SDS-PAGE and autoradiography as
previously reported [21].
3. Results
Crystallographic analyses of mouse CK2K [22] have dis-
closed extensive contacts between the N-terminal region and
the activation segment mediated by residues which are con-
served in CK2 from di¡erent organisms. These interactions
stabilize an open conformation of the activation loop which
could account for the high basal activity of CK2 catalytic
subunits as opposed to cyclin dependent protein kinase be-
longing to the same group of CK2, where this N-terminal
segment is absent and interaction with cyclin is a prerequisite
for activation.
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Fig. 1. Catalytic activity of CK2K wild type and mutants Y26F and
v1^6 in the absence and presence of the L subunit. The activities of
recombinant CK2 K wt, KY26F and Kv1^6 (0.22 pmol) in the ab-
sence and presence of increasing amounts of the L subunit were as-
sayed by using the speci¢c peptide RRRAADSDDDDD (80 WM) as
phosphorylatable substrate. Phosphorylation conditions and evalua-
tion of 32P incorporated are described in Section 2.
Fig. 2. Thermal stability of CK2K wild type and mutant Y26F ei-
ther alone (A) or in the presence of equimolar amounts of L subunit
(B). The e¡ect of pre-incubation at 45‡C for the times indicated of
K subunit either alone (0.65 pmol) or in the presence of an equimo-
lar amount of L subunit, was evaluated by assaying the residual ac-
tivity, expressed as 100% of untreated controls, toward the peptide
substrate RRRAADSDDDDD (80 WM). Phosphorylation conditions
are described in Section 2.
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To assess the actual relevance of these interactions in con-
ferring high basal activity to CK2 one of the residues impli-
cated, Tyr-26, whose side chain is connected by a hydrogen
bond to Glu-180 in the activation loop of maize CK2, was
mutated to Phe in human CK2K.
As shown in Fig. 1 the resulting mutant, Y26F, exhibits a
markedly reduced catalytic activity toward a speci¢c peptide
substrate. This is accounted for by a drop in Vmax, whereas
the KM values for either ATP or the peptide substrate are not
appreciably a¡ected (not shown). The Y26F mutant is still
able to associate with equimolar amounts of the L subunit
to give K2L2 holoenzyme whose catalytic activity is indistin-
guishable from that of the wild type holoenzyme (Fig. 1).
Consequently, as also highlighted in Fig. 1, the catalytic ac-
tivity of Y26F is stimulated by the L subunit more than it is
that of wild type (17.5-fold as compared to 2.9-fold, respec-
tively).
In maize CK2K the most N-terminal residue that makes
contact with the activation loop is Ser-2, which is the homolog
of Ser-7 in human CK2K, where a short segment of ¢ve addi-
tional residues is present. This segment is also conserved in
CK2K subunits from other vertebrates [2]. To check whether
this additional N-terminal stretch is also implicated in stabi-
lizing the active form of human CK2K, a deletion mutant, v2^
6, was generated. Its catalytic activity, as shown in Fig. 1, is
signi¢cantly reduced as compared to wild type, though not as
much as that of Y26F. Like with mutant Y26F also the ac-
tivity of the deletion mutant Kv2^6 is fully restored to wild
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Fig. 3. The K[1^30] and K[175^201] synthetic fragments counteract the stimulation of catalytic activity by L[170^215]. The synthetic peptides
K[1^30] and K[175^201], schematically illustrated in A, were added (80 WM) together with 40 WM L[170 -215] peptide in the phosphorylation as-
say of 80 WM RRRAADSDDDDD peptide substrate (B) and of 10 WM calmodulin (C) by CK2K subunit (2 pmol). Phosphate incorporation
was evaluated and quanti¢ed as described in Section 2. Reported data are means of at least three independent experiments with S.E.M. not ex-
ceeding 15%.
Fig. 4. E¡ect of the synthetic K peptides on CK2 holoenzyme auto-
phosphorylation (A) and phosphorylation of calmodulin (B) in the
presence of L[170^215]. Phosphorylation conditions are described in
Section 2. Calmodulin was 10 WM. L[170^215] peptide (40 WM) and
CK2K derived synthetic fragments (240 WM) were added as indi-
cated. Recombinant CK2 holoenzyme (1.8 pmol) was puri¢ed from
mixed extracts of K and L expressing bacteria as previously de-
scribed [31]. Only the autoradiogram is shown.
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type level upon addition of the L subunit (Fig. 1). The hyper-
stimulatory e¡ect of the L subunit observed with mutants
Y26F and v2^6 is also evident if the L subunit is replaced
by its C-terminal peptide L[155^215] previously shown [21] to
mimic positive regulation by L (not shown).
The Y26 to Phe mutation also promotes a decrease in ther-
mal stability (Fig. 2A). Unlike catalytic activity, thermal
stability is not fully restored to wild type level by association
with the L subunit (Fig. 2B).
It has to be concluded from these experiments that alter-
ations in the N-terminal segment cause signi¢cant drops both
in catalytic activity and in thermal stability. While the former,
however, is fully complemented by interactions with the L
subunit, with special reference to its C-terminal domain, the
latter persists also in the presence of the L subunit. These data
support the view that upon the formation of the holoenzyme
the L subunit replaces the N-terminal segment in keeping the
activation loop in its open conformation.
In order to corroborate this concept two peptides reproduc-
ing the N-terminal segment (residues 1^30) and the activation
loop (residues 175^201) were synthesized (Fig. 3A) and ana-
lyzed for their ability to antagonize some of the e¡ects of a
peptide reproducing the C-terminal region of the L subunit
(residues 170^215).
As shown in Fig. 3B,C, the stimulatory e¡ect of L[170^215],
tested using either a speci¢c peptide (B) or calmodulin (C) as
phosphorylatable substrate, is abolished by the N-terminal K
peptide (K[1^30]) and signi¢cantly reduced by the activation
loop peptide (K[125^201]).
Peptide L[170^215], if added in large molar excess, interferes
with the correct reconstitution of the K2L2 tetramers [29] as
judged by its ability to prevent inhibition of calmodulin phos-
phorylation [21] and to deeply alter CK2 holoenzyme auto-
phosphorylation patterns [30]. While in fact CK2 holoenzyme
normally autophosphorylates on its L subunits (residues Ser-2/
3), in the presence of C-terminal L peptides, the autophos-
phorylation of the L subunit is suppressed and the autophos-
phorylation of K becomes evident [30]. As shown in Fig.
4A,B, both these e¡ects are abolished if the peptide K[175^
201] is added together with L[170^215]. A shorter peptide
(K[188^202]), lacking the ¢rst part of the activation loop
where the residues making the main contacts with the N-ter-
minal segment are located [22], is nearly ine¡ective on both
de-inhibition of calmodulin phosphorylation and inversion of
the autophosphorylation pattern. This corroborates the view
that the peptide K[175^201] displays its e¡ect by competing
against L-K interactions that are mediated by the activation
loop, which, in the isolated K subunit, makes contact with the
N-terminal segment.
Induction of calmodulin phosphorylation by L[170^215]
was also counteracted by peptide K[1^30] (Fig. 4A), whose
perturbing e¡ect on the autophosphorylation pattern con-
versely was quite modest (Fig. 4B).
4. Discussion
The concept arising from crystallographic analysis of Zea
mays CK2K that the N-terminal segment may play a crucial
role in conferring high basal activity to the catalytic subunit
by interacting with its activation loop [22] has been validated
by showing that the mutation of Tyr-26 to Phe and the dele-
tion of the N-terminal residues 2^5 in human CK2K cause a
drop in catalytic e⁄ciency. Tyr-26 is one of the three con-
served residues mainly responsible for the contacts with the
activation loop, and it was expectable that its mutation would
have weakened these interactions. The 2^6 segment of human
CK2K is conserved in CK2 from vertebrates, while it is not
present in maize CK2K : our data show that it contributes
with the rest of the N-terminal segment to confer to human
CK2K its fully active conformation.
The additional ¢nding that impaired catalytic activity of
mutants Y26F and v2^6 can be entirely restored to wild
type level by addition of equimolar amounts of the L subunit
suggested that in CK2 holoenzyme the L subunit replaces the
N-terminal segment in maintaining the activation loop in its
open conformation. The exactness of this inference has been
corroborated by showing that a number of functions of a
peptide reproducing the C-terminal stimulatory domain of
the L subunit, namely up-regulation of the catalytic subunit,
de-inhibition of calmodulin phosphorylation by CK2 holoen-
zyme, alteration of autophosphorylation pattern, are counter-
acted to variable extents by peptides reproducing the activa-
tion loop (residues 175^201) and the N-terminal segment
(residues 1^30).
The formation of the holoenzyme would therefore imply the
displacement of the N-terminal segment from the catalytic
core and its replacement by structural elements of the L sub-
unit located in its C-terminal domain. In this respect the L
subunit would operate like cyclin A in the active CDK2 com-
plex where it keeps the activation loop in its ‘open’ confor-
mation [24]. Pertinent to this could be the following observa-
tions: (i) the regions of the catalytic core of CK2K which
make contact with the N-terminal segment (i.e. the ‘Lys-rich
stretch’ and the ‘activation loop’) are homologous to sequen-
ces of CDK2 that interact with cyclin A [22]; (ii) despite the
lack of overall similarity between the L subunit and cyclin
sequences, some motifs of cyclin A that make contact with
the catalytic subunit of CDK2 display sequence homology to
segments of the L subunit : in particular four hydrophobic
residues of cyclin A which interact with the PSTAIRE region
of CDK2, namely F267, L299, F304 and L306, are conserved
or conservatively replaced in the L subunit of CK2 (F159,
I191, Y197 and L199) being located in that part of its C-
terminal domain which is essential for physical interactions
with the catalytic subunit [19,21]. It should be noted that
the main counterpart of these residues in CDK2 is Ile-49,
conserved in CK2K (Ile-78) where it makes a hydrophobic
pocket with two residues of the N-terminal segment (V31
and W33) in maize CK2K crystallized without the L subunit.
In conclusion, a major functional di¡erence between CK2
and CDKs would consist in the presence of an N-terminal
segment which ensures basal activity to the isolated catalytic
subunit of CK2, whereas it is absent in the catalytic subunits
of CDKs which consequently are totally inactive. Another
di¡erence related to this consists in the role of the L subunits
as compared to cyclins: while the latter are invariably activa-
tory elements operating on otherwise inactive catalytic sub-
units, the L subunit displays a dual function by exerting both
positive and negative regulation on a catalytic subunit which
is already intrinsically active.
It is not clear what the fate of the N-terminal segment
might be once it is displaced by the L subunit. While a de¢nite
answer to this question will require the solution of the crystal
structure of complexes between K and L (or at least functional
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L domains) it is likely that the N-terminal segment stabilizes
the holoenzyme conformation by making new contacts within
the tetramer. While in fact the reduced catalytic activity of
mutant Y26F is fully restored upon holoenzyme formation, its
reduced thermostability persists in the holoenzyme, consistent
with the view that Tyr-26, once displaced from the activation
loop, is engaged in new interactions relevant to thermostabil-
ity.
Acknowledgements: This work was supported by grants from the
Consiglio Nazionale delle Ricerche (97.03614.PS14 and T.P. on Bio-
technology), from the Ministero dell’UniversitaØ e della Ricerca Scien-
ti¢ca e Tecnologica (MURST, PRIN 1997), from the Italian Associ-
ation for Cancer Research (AIRC), from the European Commission
(Biomed-2), from the Ministero della SanitaØ (Progetto AIDS, Istituto
Superiore di SanitaØ), from the Armenise-Harvard Foundation and
from Polo Nazionale Bioelettronica ^ Parco Scienti¢co e Tecnologico
dell’Elba. The secretarial aid of Ms. Flavia Bergamin is gratefully
acknowledged.
References
[1] Allende, J.E. and Allende, C.C. (1995) FASEB J. 9, 313^323.
[2] Pinna, L.A. and Meggio, F. (1997) Prog. Cell Cycle Res. 3, 77^
79.
[3] Marchiori, F., Meggio, F., Marin, O., Borin, G., Calderan, A.,
Ruzza, P. and Pinna, L.A. (1988) Biochim. Biophys. Acta 971,
332^338.
[4] Meggio, F., Marin, O. and Pinna, L.A. (1994) Cell. Mol. Biol.
Res. 40, 401^409.
[5] Issinger, O.-G. (1993) Pharmacol. Ther. 59, 1^30.
[6] Daya-Machim, M., Sanghera, J.S., Mogentale, T.L., Lipp, M.,
Parchomchuk, J., Hogg, J.C. and Pelech, S.L. (1994) Cancer Res.
54, 2262^2268.
[7] Faust, R.A., Gapany, M., Tristani, P., Davis, A., Adams, G.L.
and Ahmed, K. (1996) Cancer Lett. 101, 31^35.
[8] Friedrich, T.D. and Ingram, V.M. (1989) Biochim. Biophys. Acta
992, 41^48.
[9] Gapany, M., Faust, R.A., Taw¢c, S., Davis, A., Adams, G.L.
and Ahmed, K. (1995) Mol. Med. 1, 659^666.
[10] Mestres, P., Boldyre¡, B., Ebensperger, C., Hameister, H. and
Issinger, O.-G. (1994) Acta Anat. (Basel) 149, 13^20.
[11] Munstermann, U., Fritz, G., Seitz, G., Lu, Y.P., Schneider, H.R.
and Issinger, O.-G. (1990) Eur. J. Biochem. 189, 251^257.
[12] Seldin, D.C. and Leder, P. (1995) Science 267, 894^897.
[13] Kelliher, M.A., Seldin, D.C. and Leder, P. (1996) EMBO J. 15,
5160^5166.
[14] Landesman-Bollag, E., Channavajahala, P.L., Cardi¡, R.D. and
Seldin, D.C. (1998) Oncogene 16, 2965^2974.
[15] Orlandini, M., Semplici, F., Ferruzzi, R., Meggio, F., Pinna,
L.A. and Oliviero, S. (1998) J. Biol. Chem. 273, 21291^21297.
[16] HericheŁ, J.-K., Lebrin, F., Rabilloud, T., Leroy, D., Chambaz,
E.M. and Goldberg, Y. (1997) Science 276, 952^955.
[17] Dobrowolska, G., Meggio, F., Szczegielniak, J., Muszynska, G.
and Pinna, L.A. (1992) Eur. J. Biochem. 204, 299^303.
[18] De Corte, V., Gettenans, J., De Ville, Y., Waelkens, E. and
Vandenkerckhove, J. (1996) Biochemistry 35, 5472^5480.
[19] Boldyre¡, B., Meggio, F., Pinna, L.A. and Issinger, O.-G. (1993)
Biochemistry 32, 12672^12677.
[20] Meggio, F., Boldyre¡, B., Issinger, O.-G. and Pinna, L.A. (1994)
Biochemistry 33, 4336^4342.
[21] Marin, O., Meggio, F., Sarno, S. and Pinna, L.A. (1997) Bio-
chemistry 36, 7192^7198.
[22] Nie¢nd, K., Guerra, B., Pinna, L.A., Issinger, O.-G. and Schom-
burg, D. (1998) EMBO J. 17, 2451^2462.
[23] Hanks, S.K. and Hunter, T. (1995) FASEB J. 9, 576^596.
[24] Je¡rey, P.D., Russo, A.A., Polyak, K., Gibbs, E., Hurwitz, J.,
MassagueŁ, J. and Pavletich, N.P. (1995) Nature 376, 313^320.
[25] Marin, O., Meggio, F. and Pinna, L.A. (1994) Biochem. Biophys.
Res. Commun. 198, 898^905.
[26] Boldyre¡, B., Meggio, F., Pinna, L.A. and Issinger, O.-G. (1992)
Biochem. Biophys. Res. Commun. 188, 228^234.
[27] Grankowski, N., Boldyre¡, B. and Issinger, O.-G. (1991) Eur.
J. Biochem. 198, 25^30.
[28] Glass, D.B., Masaracchia, R.A., Feramisco, J.R. and Kemp, B.E.
(1978) Anal. Biochem. 87, 566^575.
[29] Marin, O., Meggio, F., Boldyre¡, B., Issinger, O.-G. and Pinna,
L.A. (1995) FEBS Lett. 363, 111^114.
[30] Meggio, F., Marin, O., Sarno, S. and Pinna, L.A. (1998) Mol.
Cell. Biochem. (in press).
[31] Boldyre¡, B., James, P., Staudenmann, W. and Issinger, O.-G.
(1993) Eur. J. Biochem. 218, 515^521.
FEBS 21265 14-12-98
S. Sarno et al./FEBS Letters 441 (1998) 29^33 33
